Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis
Authors
Keywords
-
Journal
Annals of Hepatology
Volume 28, Issue 1, Pages 100762
Publisher
Elsevier BV
Online
2022-09-29
DOI
10.1016/j.aohep.2022.100762
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A global view of the interplay between non-alcoholic fatty liver disease and diabetes
- (2022) Norbert Stefan et al. Lancet Diabetes & Endocrinology
- Metabolic Dysfunction-associated Fatty Liver Disease is Associated with Greater Impairment of Lung Function than Nonalcoholic Fatty Liver Disease
- (2022) Lei Miao et al. Journal of Clinical and Translational Hepatology
- Comprehensive Review and Updates on Holistic Approach Towards Non-Alcoholic Fatty Liver Disease Management with Cardiovascular Disease
- (2022) Nicholas W. S. Chew et al. Current Atherosclerosis Reports
- Metabolic Associated Fatty Liver Disease Increases the Risk of Systemic Complications and Mortality. A Meta-Analysis and Systematic Review of 12 620 736 Individuals
- (2022) Jingxuan Quek et al. Endocrine Practice
- Are there outcome differences between NAFLD and metabolic‐associated fatty liver disease?
- (2022) Zobair M. Younossi et al. HEPATOLOGY
- Global Prevalence and Clinical Characteristics of Metabolic Associated Fatty Liver Disease. A Meta-Analysis and Systematic Review of 10,739,607 Individuals
- (2022) Kai En Chan et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis
- (2022) Darren Jun Hao Tan et al. LANCET ONCOLOGY
- Global multi-stakeholder endorsement of the MAFLD definition
- (2022) Nahum Méndez-Sánchez et al. Lancet Gastroenterology & Hepatology
- The Effect of Diabetes and Prediabetes on the Prevalence, Complications and Mortality in Non-alcoholic Fatty Liver Disease
- (2022) Cheng Han Ng et al. Clinical and Molecular Hepatology
- NAFLD versus MAFLD: Prevalence, Outcomes and Implications of a Change in Name
- (2022) Cheng Han Ng et al. Clinical and Molecular Hepatology
- The Prevalence and Determinants of NAFLD and MAFLD and Their Severity in the VA Primary Care Setting
- (2022) Aaron P. Thrift et al. Clinical Gastroenterology and Hepatology
- Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials
- (2021) Alessandro Mantovani et al. Metabolites
- The complex link between NAFLD and type 2 diabetes mellitus — mechanisms and treatments
- (2021) Giovanni Targher et al. Nature Reviews Gastroenterology & Hepatology
- Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease
- (2021) Soo Lim et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- A clinical overview of non‐alcoholic fatty liver disease: A guide to diagnosis, the clinical features, and complications—What the non‐specialist needs to know
- (2021) Mark D. Muthiah et al. DIABETES OBESITY & METABOLISM
- Type 2 diabetes mellitus increases the risk of hepatic fibrosis in individuals with obesity and nonalcoholic fatty liver disease
- (2021) Diana Barb et al. Obesity
- Increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis with concurrent fatty liver
- (2021) Mi Na Kim et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD
- (2021) Grace En Hui Lim et al. Clinical Gastroenterology and Hepatology
- Antidiabetic Medications for Type 2 Diabetics with Nonalcoholic Fatty Liver Disease: Evidence From a Network Meta-Analysis of Randomized Controlled Trials
- (2021) Cheng Han Ng et al. Endocrine Practice
- Are the different MAFLD subtypes based on the inclusion criteria correlated with all-cause mortality?
- (2021) Xu Chen et al. JOURNAL OF HEPATOLOGY
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- NAFLD 2020: The State of the Disease
- (2020) Thomas G. Cotter et al. GASTROENTEROLOGY
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Physical Activity, Measured Objectively, is Associated With Lower Mortality in Patients With Nonalcoholic Fatty Liver Disease
- (2020) Donghee Kim et al. Clinical Gastroenterology and Hepatology
- Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in US Adults Across Blood Pressure Categories
- (2020) Stefano Ciardullo et al. HYPERTENSION
- Concordance of MAFLD and NAFLD diagnostic criteria in “real‐world” data
- (2020) Giovanni Targher LIVER INTERNATIONAL
- Clinical utility of the MAFLD definition
- (2020) Kenneth I. Zheng et al. JOURNAL OF HEPATOLOGY
- The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis
- (2019) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- 2018 ESC/ESH Guidelines for the management of arterial hypertension
- (2018) Bryan Williams et al. EUROPEAN HEART JOURNAL
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease
- (2014) L. Fedchuk et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Chronic kidney disease
- (2011) Andrew S Levey et al. LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation